Skip to main content
Premium Trial:

Request an Annual Quote

U Pitt Using WaferGen SmartChip under $3M NHLBI Grant

NEW YORK (GenomeWeb News) – WaferGen Biosystems said today that researchers at the University of Pittsburgh working under a grant from the National Institutes of Health will use the company’s PCR system in gene expression studies of lung disease.
Using a grant of around $3 million from the National Heart, Lung, and Blood Institute, the Pittsburgh scientists will use WaferGen’s SmartChip Real-Time PCR System to apply gene expression profiling to lung samples from patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
The research program also will include development and application of the PulmoSmartChip, a custom-designed SmartChip phenotyping assay for COPD and IPF that will identify and validate module networks that can help predict the natural history of the disease and the patient’s response.
The aim of the study is to identify and validate gene expression signatures and microenvironments, while generating module maps that can be used to characterize COPD and IPF and their underlying causes.
Financial terms of the agreement between WaferGen and the university were not disclosed.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.